Long-Term Follow-Up of Ruxolitinib in the Treatment of Steroid-Refractory Chronic Graft-versus-Host Disease.
Ferreira AM, Szor RS, Molla VC, Seiwald MC, de Moraes PA, da Fonseca ARBM, Xavier EM, Serpa MG, Tucunduva L, Novis Y, Arrais-Rodrigues C.
Ferreira AM, et al. Among authors: de moraes pa.
Transplant Cell Ther. 2021 Sep;27(9):777.e1-777.e6. doi: 10.1016/j.jtct.2021.06.002. Epub 2021 Jun 9.
Transplant Cell Ther. 2021.
PMID: 34118469
Free article.